| Phase 4 |
| NCT07111494 |
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic… |
Psoriatic Arthritis (PsA) |
Recruiting |
2026-08-10 |
| NCT06494072 |
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP |
Community Acquired Pneumonia in Children |
Recruiting |
2026-03-02 |
| NCT03527537 |
Gestational Diabetes and Pharmacotherapy (GAP) |
Gestational Diabetes |
Active, Not Recruiting |
2026-07-20 |
| NCT05557370 |
Immunogenicity of HPV Vaccine in Transplant Recipients. |
Chronic Kidney Diseases |
Active, Not Recruiting |
2026-05-01 |
| Phase 3 |
| NCT04298034 |
Preeclampsia Postpartum Antihypertensive Treatment |
Preeclampsia |
Active, Not Recruiting |
2026-07-20 |
| NCT05687344 |
Intensive Postpartum Antihypertensive Treatment |
Hypertensive Disorder of Pregnancy |
Active, Not Recruiting |
2026-07-20 |
| Phase 2 |
| NCT06031428 |
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly… |
Diabetes Mellitus, Type 2 |
Recruiting |
2026-10-06 |
| NCT04383262 |
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction |
Laryngopharyngeal Reflux |
Recruiting |
2026-09-10 |
| NCT07226713 |
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That… |
Prostate Cancer |
Recruiting |
2026-09-09 |
| NCT04838041 |
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in… |
Chronic Phase Chronic Myelogenous Leukemia |
Recruiting |
2026-08-25 |
| NCT06594939 |
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly… |
Diffuse Large B Cell Lymphoma (DLBCL) |
Recruiting |
2026-08-25 |
| NCT05045950 |
Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed… |
Brain Metastases |
Recruiting |
2026-07-29 |
| NCT04040205 |
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway… |
Chondrosarcoma |
Recruiting |
2026-07-28 |
| NCT06906887 |
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT… |
Esophageal Cancer |
Recruiting |
2026-07-28 |
| NCT04683315 |
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression… |
Pancreatic Cancer |
Recruiting |
2026-03-05 |
| NCT06517641 |
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal… |
Severe Aplastic Anemia |
Recruiting |
2026-02-17 |
| NCT04240054 |
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in… |
Multiple Myeloma |
Recruiting |
2026-01-28 |
| NCT03322995 |
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial |
Pancreatic Cancer |
Recruiting |
2026-01-08 |
| NCT06361940 |
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term… |
Breast Cancer |
Recruiting |
2025-10-14 |
| NCT06305715 |
Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell… |
Non Small Cell Lung Cancer |
Recruiting |
2025-10-07 |
| NCT06930638 |
MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes |
Stroke |
Recruiting |
2025-09-25 |
| NCT05808686 |
Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals |
Aging |
Recruiting |
2025-09-23 |
| NCT03571334 |
Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy |
Peripheral Neuropathy Due to Chemotherapy |
Recruiting |
2021-12-23 |
| NCT04746209 |
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT |
B-cell Acute Lymphoblastic Leukemia |
Recruiting |
2021-09-17 |
| NCT06704100 |
Oral Fosamprenavir for GERD |
Refractory Gastroesophageal Reflux Disease |
Not Yet Recruiting |
2026-09-10 |